OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Rhea-AI Summary

OrthoPediatrics (Nasdaq: KIDS) will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. The company will host a conference call the same day at 4:30 p.m. ET to discuss the results.

Investors can access a live and archived webcast on the company's Investors page in the Events & Presentations section; the replay will be available for at least 90 days.

Key Figures

Earnings release date: February 26, 2026 Conference call time: 4:30 p.m. ET Webcast replay duration: 90 days

3 metrics

Earnings release date February 26, 2026 Scheduled Q4 and full-year 2025 financial results release

Conference call time 4:30 p.m. ET Start time for earnings conference call on February 26, 2026

Webcast replay duration 90 days Replay availability period for the earnings webcast

Market Reality Check

Price: $16.72 Vol: Volume 103,046 vs 20-day ...

normal vol

$16.72 Last Close

Volume Volume 103,046 vs 20-day average 139,569 (relative volume 0.74) ahead of earnings date. normal

Technical Price 17.22 is trading below the 200-day MA of 19.42.

Peers on Argus

Sector moves appear stock-specific: KIDS was up 0.82% with mixed peers (e.g., TM...

1 Up

Sector moves appear stock-specific: KIDS was up 0.82% with mixed peers (e.g., TMCI -3.81%, LAB -3.6%, CTKB +0.57%). Scanner only flagged VREX up 5.34%, suggesting no broad momentum in close peers.

Common Catalyst Another peer, CTKB, also issued an earnings date press release, pointing to calendar-driven news rather than fundamental shifts.

Historical Context

5 past events · Latest: Feb 03 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 03	Regulatory clearance	Positive	-1.9%	FDA 510(k) clearance expanding iotaSOFT use to younger patients.
Jan 12	Prelim results & guidance	Positive	+9.8%	Record preliminary 2025 revenue and introduction of 2026 revenue guidance.
Nov 13	Product launches	Positive	-0.4%	Launch of two PediHip bracing systems for pediatric hip conditions.
Nov 04	Investor conferences	Neutral	-1.3%	Participation in several healthcare investor conferences with webcast access.
Oct 28	Q3 2025 earnings	Positive	-0.3%	Q3 revenue growth and higher adjusted EBITDA alongside ongoing net losses.

Pattern Detected

Recent history shows frequent divergence where shares traded flat to lower on generally positive operational and financial updates.

Recent Company History

Over the last several months, KIDS reported multiple growth-oriented updates. On Jan 12, 2026, it announced record preliminary 2025 revenue of $236.1M with 15% growth and issued 2026 revenue and EBITDA guidance, and the stock rose 9.83%. Other news—such as FDA 510(k) clearance for the iotaSOFT system, new PediHip bracing launches, and Q3 2025 results with higher revenue and EBITDA—saw mild negative price reactions, highlighting a tendency for good news to be met with muted or slightly negative trading.

Market Pulse Summary

This announcement sets the timetable for KIDS’ fourth quarter and full-year 2025 results on February...

Analysis

This announcement sets the timetable for KIDS’ fourth quarter and full-year 2025 results on February 26, 2026, including a 4:30 p.m. ET conference call and 90-day webcast replay. Context from recent history shows record preliminary 2025 revenue and formal 2026 guidance already disclosed, alongside product and regulatory milestones. Investors may focus on how final audited figures compare with those preliminaries and on management’s commentary regarding growth, profitability, and capital allocation.

AI-generated analysis. Not financial advice.

WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, February 26, 2026 at 4:30 p.m. ET to discuss the results.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 85 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406

FAQ

When will OrthoPediatrics (KIDS) report Q4 and full year 2025 financial results?

OrthoPediatrics will report fourth quarter and full year 2025 results on February 26, 2026 after market close. According to the company, the release is scheduled for Thursday, February 26, 2026 and will be followed by a conference call at 4:30 p.m. ET the same day.

What time is the OrthoPediatrics (KIDS) conference call for the February 26, 2026 results?

The conference call is scheduled for 4:30 p.m. ET on February 26, 2026 to discuss results. According to the company, investors may listen to the live webcast and the company will also provide an archived replay on its Investors Events & Presentations page.

How can investors listen to OrthoPediatrics (KIDS) Q4 2025 earnings call on February 26, 2026?

Investors can listen via a live webcast on the OrthoPediatrics Investors page in Events & Presentations. According to the company, the webcast will be available live and archived for replay on the company's website for at least 90 days after the event.

How long will the OrthoPediatrics (KIDS) earnings webcast replay be available after February 26, 2026?

The webcast replay will be available for at least 90 days after the event. According to the company, the February 26, 2026 webcast of the fourth quarter and full year 2025 results will be accessible on the Investors page and archived for a minimum 90-day period.

Where on the website will OrthoPediatrics (KIDS) post the Q4 and full year 2025 webcast?

The webcast will be posted on the OrthoPediatrics Investors page, in the Events & Presentations section. According to the company, investors can access both the live webcast and the archived replay via that specific Investors page on the company's website.